Versant Capital Management »

Anavex Life Sciences shares owned by Versant Capital Management

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $13k 1.5k 8.90
2025-06-30 $14k 1.5k 9.22
2025-03-31 $13k 1.5k 8.58
2024-12-31 $16k 1.5k 10.74

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Anavex Life Sciences

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Susquehanna International
Two Sigma Investments
Nwam
Northern Trust
Two Sigma Advisers
Charles Schwab Investment Management
Citadel Advisors
Morgan Stanley
LPL Financial
UBS Group
Private Advisor

View all funds holding Anavex Life Sciences